Insulin Aspart
Brand Formulations & Prices
3 brands sorted by unit price
📖 Official Clinical Monograph
DGDA Approved Prescribing GuidelinesFiasp FlexTouch is a rapid acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.
Insulin Insulin Aspart is contraindicated-
during episodes of hypoglycemia
in patients with hypersensitivity to Insulin Aspart or one of its excipients
Side effects of Fiasp FlexTouch are hypoglycemia, allergic reactions, injection site reaction, lipodystrophy, pruritus and rash.
Dose adjustment and monitoring
: Blood glucose should be monitored in all patients treated with insulin. Fiasp FlexTouch regimens should be modified cautiously and only under medical supervision.
The primary activity of Insulin Aspart is the regulation of glucose metabolism. Insulin Aspart bind to the insulin receptors on muscle and fat cells and lower blood glucose by facilitating the cellular uptake of glucose and simultaneously inhibiting the output of glucose from the liver.